Acting Attorney General Todd Blanche issues a final order moving medical cannabis products to Schedule III, following a 2025 ...
Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...
The Justice Department’s reclassification announcement Thursday could bring more clarity and opportunity to a field long ...
A Justice Department order reclassifying medical marijuana as could throw a lifeline to a struggling medical-use industry in ...
Global Drug Discovery Services Market OverviewThe global drug discovery services market is set to witness strong expansion, ...
Key Takeaways Medspas and other entities operating in the aesthetic space that dispense or administer prescription drugs should assess whether they have obligations as dispensers under the DSCSA and ...
This morning, the U.S. Department of Justice issued a final order, effective April 22, 2026, placing Food and Drug Administration (FDA)-approved drug products containing marijuana, as well as ...
TOPEKA (KSNT) – Governor Laura Kelly has vetoed a bill Thursday that would have required all Kansas high school students to ...
AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease ...
On April 22, researchers introduced two separate AI tools aimed at easing persistent challenges in drug development. A University of Oregon team developed a model that uses AI and physics data to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results